Research map: Bayesian Workflow for Minimal PBPK Models: Case Study of Dapagliflozin

Back to the article

Papers in this map

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews · Matthew James Page · 2021 · 106363 citations · Cited by this paper
  2. Sex‐Related Differences in Physiologically‐Based Biopharmaceutics Modeling · 2026 · Related
  3. Stan : A Probabilistic Programming Language · Bob Carpenter · 2017 · 8394 citations · Cited by this paper
  4. Follow‐Up Bias in Tumor Dynamic Modeling: A Comparison of Classical and Neural‐ODE Approaches · 2026 · Related
  5. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction · John J.V. McMurray · 2019 · 7146 citations · Cited by this paper
  6. Evaluating Preclinical‐to‐Human Bioavailability Classification Using Smooth ROC Curve Estimation · 2026 · Related
  7. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC · Aki Vehtari · 2016 · 5686 citations · Cited by this paper
  8. Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria · 2026 · Related
  9. Dapagliflozin in Patients with Chronic Kidney Disease · Hiddo J.L. Heerspink · 2020 · 5532 citations · Cited by this paper
  10. Hybrid Systems Modeling of Donor T‐Cell Responses and Graft‐Versus‐Host‐Disease After Posttransplantation Cyclophosphamide Administration · 2026 · Related
  11. Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate · Lesley A. Stevens · 2006 · 2977 citations · Cited by this paper
  12. Assessing Covariate Clinical Relevance in High‐Dimensional PK Analysis: A Comparison of SCM +, FFEM , and FREM Approaches · 2026 · Related
  13. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey · Josef Coresh · 2002 · 2779 citations · Cited by this paper
  14. Integrative QSP Modeling of Cancer Stem Cells in Triple‐Negative Breast Cancer: Impacts on Tumor Immunity and Response to Immune Checkpoint Inhibitors · 2026 · Related
  15. A Gentle Introduction to Bayesian Analysis: Applications to Developmental Research · Rens van de Schoot · 2013 · 803 citations · Cited by this paper
  16. Physiologically Based Pharmacokinetic Model of Brigatinib in Healthy Volunteers and Patients With Cancer · 2026 · Related
  17. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS · Paul Christopher Lambert · 2005 · 521 citations · Cited by this paper
  18. Objective First, Method Second: Why the Estimand Definition Comes First in Pharmacometric Covariate Modeling · 2026 · Related
  19. Robust meta‐analytic‐predictive priors in clinical trials with historical control information · Heinz Schmidli · 2014 · 483 citations · Cited by this paper
  20. Butorphanol Pharmacokinetics Across Species: Meta‐Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling · 2026 · Related
  21. Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans? · Jiwen Liu · 2012 · 226 citations · Cited by this paper
  22. Applications of minimal physiologically-based pharmacokinetic models · Yanguang Cao · 2012 · 202 citations · Cited by this paper
  23. A General Purpose Pharmacokinetic Model for Propofol · Douglas J. Eleveld · 2014 · 182 citations · Cited by this paper
  24. Pharmacodynamic Model of Sodium–Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology · Tristan S. Maurer · 2011 · 37 citations · Cited by this paper
  25. An industry perspective on current QSP trends in drug development · L. Cucurull-Sanchez · 2024 · 36 citations · Cited by this paper
  26. Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial · Weiqing Wang · 2024 · 33 citations · Cited by this paper
  27. Bayesian aggregation of average data: An application in drug development · Sebastian Weber · 2018 · 26 citations · Cited by this paper
  28. Flexible and efficient Bayesian pharmacometrics modeling using Stan and Torsten, Part I · Charles C. Margossian · 2022 · 20 citations · Cited by this paper
  29. Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus · David Busse · 2019 · 16 citations · Cited by this paper
  30. Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease · Annemarie B. van der Aart‐van der Beek · 2021 · 15 citations · Cited by this paper
  31. Using Bayesian Dynamic Borrowing to Maximize the Use of Existing Data: A Case-Study · Dawn Edwards · 2023 · 15 citations · Cited by this paper
  32. Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling · Bram C. Agema · 2024 · 15 citations · Cited by this paper
  33. A model‐based approach to investigating the relationship between glucose‐insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes · Millie Shah · 2020 · 10 citations · Cited by this paper
  34. Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus · Johanna Melin · 2022 · 9 citations · Cited by this paper
  35. Enhancing pharmacometric modeling with full Bayesian inference and Student’s t-Based M3 Censoring: A simulated population PK study on robust handling of outliers and censored data · Yiming Cheng · 2025 · 6 citations · Cited by this paper
  36. Evaluation of the Pharmacokinetics of Dapagliflozin in Patients With Chronic Kidney Disease With or Without Type 2 Diabetes Mellitus · Robert C. Penland · 2022 · 5 citations · Cited by this paper
  37. Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus · Johanna Melin · 2023 · 4 citations · Cited by this paper
  38. Untitled · Cited by this paper

Source: OpenAlex (CC0)